e-learning
resources
Paris 2018
Monday, 17.09.2018
Tuberculosis comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Adenosine deaminase in the COPD pathogenesis in patients with pulmonary tuberculosis
L. Kiryukhina (Saint-Petersburg, Russian Federation), M. Dyakova (Saint-Petersburg, Russian Federation), D. Esmedlyaeva (Saint-Petersburg, Russian Federation)
Source:
International Congress 2018 – Tuberculosis comorbidities
Session:
Tuberculosis comorbidities
Session type:
Thematic Poster
Number:
2718
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Kiryukhina (Saint-Petersburg, Russian Federation), M. Dyakova (Saint-Petersburg, Russian Federation), D. Esmedlyaeva (Saint-Petersburg, Russian Federation). Adenosine deaminase in the COPD pathogenesis in patients with pulmonary tuberculosis. 2718
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Activity of lysozyme and adenosine deaminase in patients with pulmonary tuberculosis
Source: International Congress 2018 – Diagnosis of tuberculosis
Year: 2018
The worth of serum adenosine deaminase levels in patients with pulmonary tuberculosis for follow-up the disease
Source: Eur Respir J 2004; 24: Suppl. 48, 425s
Year: 2004
Serum adenosine deaminase (ADA) activities and neopterine levels during therapy in patients with pulmonary tuberculosis and community-acquired pneumonia
Source: Annual Congress 2010 - What is new in the diagnosis of tuberculosis?
Year: 2010
Adenosine deaminase level in the diagnosis of tuberculosis pleural effusions- a study of 205 patients
Source: Eur Respir J 2004; 24: Suppl. 48, 425s
Year: 2004
Adenosine desaminase /ADA/ in diagnosing of primary tuberculosis in children
Source: Eur Respir J 2002; 20: Suppl. 38, 580s
Year: 2002
Endobrochites of specific genesis in patients with pulmonary tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 201s
Year: 2004
Change in pulmonary function among patients with bronchiectasis with or without non-tuberculous mycobacterial pulmonary disease
Source: International Congress 2019 – Complex respiratory infections in clinical practice
Year: 2019
Adenosine-related mechanisms in the COPD pathogenesis in pulmonary tuberculosis (PT) patients
Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair
Year: 2020
Intestinal parasiroses in patients with pulmonary tuberculosis
Source: Annual Congress 2010 - Special treatment options in tuberculosis
Year: 2010
The relation of the pleural thickening in tuberculosis pleurisy with the activity of adenosine deaminase
Source: Eur Respir J 2004; 24: Suppl. 48, 35s
Year: 2004
Adenosine-regulated mechanisms in the pathogenesis of ventilation disorders in patients with pulmonary tuberculosis
Source: Virtual Congress 2021 – Molecular pathology and cell biology of pulmonary diseases
Year: 2021
Adenosine deaminase for diagnosis of pleural tuberculosis in intermediate-low prevalence scenarios
Source: Annual Congress 2013 –Tuberculosis diagnosis
Year: 2013
Pleural fluid and serum adenosine deaminase (ADA) activities reflects the severity of lung tuberculosis
Source: Annual Congress 2008 - Diagnosis of tuberculosis: problems and perspectives
Year: 2008
Pulmonary involvement in extrapulmonary tuberculosis patients
Source: Annual Congress 2011 - Pulmonary and extrapulmonary tuberculosis
Year: 2011
History of pulmonary tuberculosis was associated with lung microbiome change in patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD
Year: 2020
Risk of nontuberculous mycobacterial pulmonary disease with obstructive lung disease
Source: Eur Respir J 2016; 48: 928-931
Year: 2016
Non-tuberculous mycobacterial lung disease and COPD
Source: Eur Respir Monogr 2015; 69: 172-184
Year: 2015
The profile of patients with pulmonary and extrapulmonary tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 312s
Year: 2001
Characterization of the aetiological agent in patients with pulmonary tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 12s
Year: 2006
COPD and other pulmonary diseases
Source: Eur Respir Monogr 2015; 67: 161-178
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept